At-Home Testing Market size was valued at USD 12.73 Billion in 2023 and the total At-Home Testing Revenue is expected to grow at a CAGR of 8.2 % from 2024 to 2030, reaching nearly USD 22.10 Billion in 2030.At-Home Testing Market Overview:
Self-tests detect current infection and are sometimes also called home tests, or over-the-counter (OTC) tests. At-home testing means testing instruments that help people perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at a very affordable rate. Self-tests are usually the advanced versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and performed by the common person.To know about the Research Methodology :- Request Free Sample Report The growth of the At Home Testing market is primarily attributed to the increasing prevalence of chronic diseases, the growth of at-home testing kits for disease diagnosis, and rising awareness about health among consumers. The market has seen significant growth owing to the rising disposable incomes, the presence of domestic businesses, and the population's increasing knowledge of home care testing. In addition, the public's attention has shifted towards preventive healthcare, leading to a rise in demand for at-home testing products. Major players in the At-Home Testing market have capitalized on the opportunities by improving the procedures, packing, and instructions to simplify the exam-taking process for consumers. Canada has extended the shelf life of the Abbott Pan bio–Nasal COVID-19 Rapid Test Device to 24 months from the date of manufacture. Uganda has become the first country to adopt HIV self-tests procured under the terms of Medac cess’ volume guarantee to Guangzhou Wondfo Biotech (Wondfo). The decision marks a step forward in the country’s efforts to ensure people know their HIV status and access treatment where needed. The world-first pilot program, conducted by a hospital trust in the UK, allows pregnant women to take the glucose tolerance test at home using a home care testing kit in April 2023. Continuous advancements in the field drive the At Home Market growth.
At-Home Testing Market Dynamics:
The Dynamic Growth of the Self-Testing Market Increased funding and investments in the self-testing market have created a dynamic landscape, driving significant advancements in diagnostic technologies. The influx of financial support stems from various organizations, both public and private, and market players. The investments aim to boost the development of innovative, reliable, and user-friendly self-testing solutions. At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into space as they rapidly manufacture self-test kits. Widespread availability is also attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, the self-testing kits are available without any prescription. The At-Home Testing market has extended substantially, encompassing various sectors such as home pregnancy tests, glucose monitoring for diabetes, DNA testing, and COVID-19 tests. The convenience and speed offered by the diagnostic kits have fuelled their demand, with consumers increasingly opting for at-home diagnostics. Government initiatives and partnerships promote self-testing, enhancing its role in public health and healthcare management.The Rise of Advanced Self-Testing Kits The industry is growing owing to the simple accessibility of self-testing kits via online retailers and pharmacies without a prescription. The rising use of customized self-assessment kits for the diagnosis of HIV disease has increased the number of R&D activities in the field of at-home testing kits or medical devices enhanced healthcare services, and significant investments by the government to improve healthcare infrastructure Advanced and modern self-test kits integrate seamlessly with digital health platforms and mobile applications. The integration allows users to track and monitor their results digitally, providing a more comprehensive and accessible overview of their health status. Some pregnancy kits that are trending include digital test kits and pregnancy strip self-tests. In the digital pregnancy kit result shown in words as well as the test is over 99% accurate at detecting pregnancy from the day of the expected period. Pregnancy strips are trending in the U.S. market owing to their various features like accurate and highly reliable pregnancy test strips. Challenges and Hurdles in the At-Home Testing Market The projected growth of the global at-home testing market is expected to be hampered by the rising number of product recalls of self-testing kits by regulatory bodies like the USA FDA. There are multiple pieces of evidence of such recalls in the market. The variables in total propose an adverse consequence on the formative development of the at-home testing market. Stringent regulatory requirements for the approval of at-home testing kits pose a challenge for manufacturers. Navigating complex regulatory landscapes may slow down the introduction of new products to the market. Additionally, a false positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results.
At-Home Testing Market Segment Analysis:
By products, the Kits segment had dominated the market with a share of 65 % in 2023. home diagnostic kits are designed to serve two basic purposes, early disease detection and disease therapy monitoring. kits are used for the rapid diagnostic of different diseases. In the test no need for a medical expert. Self-tests are comfortable and convenient as they taken at any time and require a small procedure. The self-test kits are used in different conditions like, pregnancy self-test, HIV self-test, self-test kits for infertility, self-test kits for STIs, and others. Increasing funding and investments by various organizations as well as market players for the development of novel and robust diagnostics has created lucrative opportunities for the self-testing industry. 1. In February 2023, Abingdon Health plc entered into a distribution agreement with Salignostics to extend sales of the latter’s saliva-based pregnancy test kits in Ireland. 2. In April 2023, the India-based start-up Cervicheck received approval from the Central Drugs Standard Control Organization (CDSCO) for the commercialization of its kit in India. The kit is used for the diagnosis of Human Papillomavirus (HPV). the numbers of HIV patients are increasing day by day and the demand for HIV tests is trending. For example; there are currently 1.1 million people living with HIV in the United States. Nearly 39,000 people are newly diagnosed with HIV each year. Additionally, around 1 in 7 Americans are living with HIV according to the U.S. Department of Health & Human Services. key companies engaged in the at-home testing kits market (which have also been profiled in this market report; the complete list of companies is available in the full report) include ACON Laboratories, AdvaCare Pharma USA, Apex Biotechnology, I-SENS, Oak Tree Health, TaiDoc Technology, and VivaCheck Laboratories. The packages were printed and the tests were distributed.By Usage, the disposable segment generated the largest share and also grow at the fastest growth rate. Self-testing has introduced novel opportunities for patient detection, diagnosis, and treatment. Disposable kits are particularly appealing owing to their convenience and user-friendliness. They do away with the need for intricate preparation or cleaning, ensuring a clean and hassle-free experience. The advantages, combined with enhanced safety features, are poised to drive substantial growth in the segment over the forecast period. Disposable kits offer exceptional usability due to their convenient and user-friendly nature. They eliminate the need for complex preparation or cleaning, ensuring a hygienic and hassle-free experience. Such advantages of disposable kits along with improved safety are likely to accelerate segment growth during the forecast period.
At-Home Testing Market Regional Analysis:
North America dominated the market in 2023 with a market share of 83%. HIV & diabetes are affecting specific populations in the United States especially ethnic and racial minorities & people of all ages are diabetics which is also driving the self-testing market in the United States. Non-existent, time-consuming, or unclear national registration and regulatory processes for IVDs make it difficult to introduce and scale up HIV self-testing in both public and private sector markets. In addition, the lack of policies and/or product registration in the U.S. where the test kit is manufactured or assembled is also a barrier, like certificates of free sale are needed to export and import self-tests in the U.S. An increasing number of women have preferred the pregnancy tests at home by themselves owing to several companies are entering the pregnancy self-kit market and they were added new features. The US home DNA testing market is set to trend on the historic pattern of the bust and boom through the forecast period. The country is home to some of the biggest pharma and biotechnology companies globally and is set to increase their business with high returns. The U.S. and Canada are one of the largest markets for home DNA testing globally. PHASE Scientific America, a global company focusing on offering innovative biomedical diagnostics solutions launched INDICAID Health, the company’s at-home health tests and digital health experiences. After obtaining the test results, the users required guidance or treatment advice through the company’s virtual platform. Such development boosts the product adoption rate. The Asia Pacific region is projected to develop at the fastest CAGR over the forecast period. The rising number of activities related to research & development of novel therapeutics for infections, the improving healthcare sector, and government initiatives to reduce disease burden are the key factors driving regional market growth. China, Japan, India, and Australia are major economies in APAC. Homecare setting in developing countries is the major factor driving the growth of the APAC Home Testing Devices Market. The growing developments in healthcare in various developing are expected to serve as vital growth opportunities for the market growth. Germany dominates the European at-home testing kits market in terms of market share and market revenue and continue to flourish its dominance through the forecast period. Owing to the country's high healthcare expenditure and the increasing awareness about the European at-home testing kits market. Some of the major players operating in the Europe at-home testing kits market are Abbott, ACON Laboratories, Inc., Rapikit, BD, Cardinal Health, B. Braun Melsungen AG, Piramal Enterprises Ltd., Siemens Healthcare GmbH, Quidel Corporation, Bionime Corporation, SA Scientific, ARKRAY USA, Inc., Nova Biomedical, AdvaCare Pharma, AccuBioTech Co., Ltd., Atlas Medical UK, TaiDoc Technology Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Sensing Self, PTE. Ltd, Atomo Diagnostics, RUNBIO BIOTECH CO., LTD., Mylan N.V. (a subsidiary of Viatris, Inc.), MP BIOMEDICALS, VedaLab, Shanghai Chemtron Biotech Co.Ltd., and Ascensia Diabetes Care Holdings AG among other domestic players.At-Home Testing Market Competitive Landscape: 1. In January 2023, the National Institutes of Health in collaboration with the Administration for Strategic Preparedness and Response (ASPR) launched the Home Test to Treat program, an entirely virtual community health intervention, for patients suffering from COVID-19. Department of Health and Human Services, has launched the Home Test to Treat program, an entirely virtual community health intervention that provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities. The program, first announced by the White House (link is external) in September 2022, and make antiviral treatment available for eligible individuals who receive a positive test result, which prevent severe illness, hospitalization or death. 2. In February 2023, R.R. Donnelley & Sons Company (RRD) recognized the increasing demand for at-home testing and expanded its diagnostic test kit solution accordingly. By doing so, RRD aims to cater to the growing market need for convenient and accessible diagnostic solutions that can be used in the comfort of one's home. This expansion allows RRD to provide customers with reliable and user-friendly test kits, helping individuals monitor their health and detect diseases early while enjoying the benefits of at-home testing. 3. In May 2023, Healthy.io collaborated with Boehringer Ingelheim Pharmaceuticals to support at-home testing and to provide educational information to patients at risk of chronic kidney disease (CKD) by transforming the smartphone camera into a medical device. Through the collaboration, Boehringer Ingelheim will work with Healthy.io's Minuteful Kidney test kit to explore the operational aspects of an at-home UACR (urine albumin-to-creatinine ratio) test kit – the first and only FDA-cleared, smartphone powered at-home ACR test – to at-risk, previously untested patients. It will help to engage the patients in their kidney health by conducting a smartphone-powered test at the time and place of their choosing as a step-in screening for earlier identification of CKD. 4. In July 2023, LifeCell International launched self-sampling test kits intending to allow people to collect cell swabs and tissue samples in the privacy of their homes which is used for detecting Human Papillomavirus (HPV) which leading cervical cancer in women and sexually transmitted infections like syphilis or gonorrhea. LIfeCell International, which started as a stem-cell collection and cryo-storage agency, has recently branched out into products that focus on fertility and reproductive health, baby development, and genetic assessments. In addition to home sample collection kits for STD and HPV test, the company has launched kits to test a number of other health factors from sperm health to hormonal health, fertility, Omega-3 fatty acids like DHA that determine fatal and child development, and perimenopause.
At-Home Testing Market Scope: Inquire before buying
Global At-Home Testing Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 12.73 Bn. Forecast Period 2024 to 2030 CAGR: 8.2% Market Size in 2030: US $ 22.10 Bn. Segments Covered: by Product Kits Devices Strips by Sample Blood Urine Stool by Application Blood Pressure Test Diabetes and Glucose Tests Cholesterol and Triglycerides Tests Pregnancy Test STD /STI Test Urinary Tract Infection Test Cancer Test Celiac disease Test Thyroid Test Transaminase Test Anemia Test Allergy Test by End-User Retail Pharmacies Hospital Pharmacies Online Pharmacies At-Home Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)At-Home Testing Key Players:
1. BD (Becton, Dickinson and Company) (U.S.) 2. LifeScan IP Holdings, LLC (U.S.) 3. Abbott (U.S.) 4. ACON Laboratories, Inc. (U.S.) 5. Quidel Corporation (U.S.) 6. ARKRAY USA, Inc. (U.S.) 7. Nova Biomedical (U.S.) 8. Cardinal Health (U.S.) 9. OraSure Technologies (U.S.) 10. Everlywell, Inc. (U.S.) 11. SA Scientific Ltd. (U.S.) 12. MP BIOMEDICALS (U.S.) 13. Chembio Diagnostics, Inc. (U.S.) 14. BTNX INC. (Canada) 15. Biolytical Laboratories Inc. (Canada) 16. Siemens Healthcare GmbH (Germany) 17. Drägerwerk AG & Co. KGaA (Germany) 18. F. Hoffmann-La Roche Ltd (Switzerland) 19. Ascensia Diabetes Care Holdings AG (Switzerland) 20. PRIMA Lab SA (Switzerland) 21. BioSure (U.K.) 22. Sterilab Services (France) 23. Biosynex (France) Frequently Asked Questions: 1] What segments are covered in the At Home Testing Market report? Ans. The segments covered in the At Home Testing Market report are based on, Product, Sample, Application, and End Users. 2] Which region is expected to hold the highest share in the At Home Testing Market? Ans. The North American region is expected to hold the highest share of the At Home Testing Market. 3] What is the market size of the At Home Testing Market by 2030? Ans. The market size of the At Home Testing Market by 2030 will be $ 22.10 Billion. 4] What is the forecast period for the At Home Testing Market? Ans. The Forecast period for the At Home Testing Market is 2024- 2030.
1. At-Home Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. At-Home Testing Market: Dynamics 2.1. At-Home Testing Market Trends by Region 2.1.1. North America At-Home Testing Market Trends 2.1.2. Europe At-Home Testing Market Trends 2.1.3. Asia Pacific At-Home Testing Market Trends 2.1.4. Middle East and Africa At-Home Testing Market Trends 2.1.5. South America At-Home Testing Market Trends 2.2. At-Home Testing Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America At-Home Testing Market Drivers 2.2.1.2. North America At-Home Testing Market Restraints 2.2.1.3. North America At-Home Testing Market Opportunities 2.2.1.4. North America At-Home Testing Market Challenges 2.2.2. Europe 2.2.2.1. Europe At-Home Testing Market Drivers 2.2.2.2. Europe At-Home Testing Market Restraints 2.2.2.3. Europe At-Home Testing Market Opportunities 2.2.2.4. Europe At-Home Testing Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific At-Home Testing Market Drivers 2.2.3.2. Asia Pacific At-Home Testing Market Restraints 2.2.3.3. Asia Pacific At-Home Testing Market Opportunities 2.2.3.4. Asia Pacific At-Home Testing Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa At-Home Testing Market Drivers 2.2.4.2. Middle East and Africa At-Home Testing Market Restraints 2.2.4.3. Middle East and Africa At-Home Testing Market Opportunities 2.2.4.4. Middle East and Africa At-Home Testing Market Challenges 2.2.5. South America 2.2.5.1. South America At-Home Testing Market Drivers 2.2.5.2. South America At-Home Testing Market Restraints 2.2.5.3. South America At-Home Testing Market Opportunities 2.2.5.4. South America At-Home Testing Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For At-Home Testing Industry 2.8. Analysis of Government Schemes and Initiatives For At-Home Testing Industry 2.9. At-Home Testing Market Trade Analysis 2.10. The Global Pandemic Impact on At-Home Testing Market 3. At-Home Testing Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. At-Home Testing Market Size and Forecast, by Product (2023-2030) 3.1.1. Kits 3.1.2. Devices 3.1.3. Strips 3.2. At-Home Testing Market Size and Forecast, by Sample (2023-2030) 3.2.1. Blood 3.2.2. Urine 3.2.3. Stool 3.3. At-Home Testing Market Size and Forecast, by Application (2023-2030) 3.3.1. Blood Pressure Test 3.3.2. Diabetes and Glucose Tests 3.3.3. Cholesterol and Triglycerides Tests 3.3.4. Pregnancy Test 3.3.5. STD /STI Test 3.3.6. Urinary Tract Infection Test 3.3.7. Cancer Test 3.3.8. Celiac disease Test 3.3.9. Thyroid Test 3.3.10. Transaminase Test 3.3.11. Anemia Test 3.3.12. Allergy Test 3.4. At-Home Testing Market Size and Forecast, by End User (2023-2030) 3.4.1. Retail Pharmacies 3.4.2. Hospital Pharmacies 3.4.3. Online Pharmacies 3.5. At-Home Testing Market Size and Forecast, by Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America At-Home Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America At-Home Testing Market Size and Forecast, by Product (2023-2030) 4.1.1. Kits 4.1.2. Devices 4.1.3. Strips 4.2. North America At-Home Testing Market Size and Forecast, by Sample (2023-2030) 4.2.1. Blood 4.2.2. Urine 4.2.3. Stool 4.3. North America At-Home Testing Market Size and Forecast, by Application (2023-2030) 4.3.1. Blood Pressure Test 4.3.2. Diabetes and Glucose Tests 4.3.3. Cholesterol and Triglycerides Tests 4.3.4. Pregnancy Test 4.3.5. STD /STI Test 4.3.6. Urinary Tract Infection Test 4.3.7. Cancer Test 4.3.8. Celiac disease Test 4.3.9. Thyroid Test 4.3.10. Transaminase Test 4.3.11. Anemia Test 4.3.12. Allergy Test 4.4. North America At-Home Testing Market Size and Forecast, by End User (2023-2030) 4.4.1. Retail Pharmacies 4.4.2. Hospital Pharmacies 4.4.3. Online Pharmacies 4.5. North America At-Home Testing Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States At-Home Testing Market Size and Forecast, by Product (2023-2030) 4.5.1.1.1. Kits 4.5.1.1.2. Devices 4.5.1.1.3. Strips 4.5.1.2. United States At-Home Testing Market Size and Forecast, by Sample (2023-2030) 4.5.1.2.1. Blood 4.5.1.2.2. Urine 4.5.1.2.3. Stool 4.5.1.3. United States At-Home Testing Market Size and Forecast, by Application (2023-2030) 4.5.1.3.1. Blood Pressure Test 4.5.1.3.2. Diabetes and Glucose Tests 4.5.1.3.3. Cholesterol and Triglycerides Tests 4.5.1.3.4. Pregnancy Test 4.5.1.3.5. STD /STI Test 4.5.1.3.6. Urinary Tract Infection Test 4.5.1.3.7. Cancer Test 4.5.1.3.8. Celiac disease Test 4.5.1.3.9. Thyroid Test 4.5.1.3.10. Transaminase Test 4.5.1.3.11. Anemia Test 4.5.1.3.12. Allergy Test 4.5.1.4. United States At-Home Testing Market Size and Forecast, by End User (2023-2030) 4.5.1.4.1. Retail Pharmacies 4.5.1.4.2. Hospital Pharmacies 4.5.1.4.3. Online Pharmacies 4.5.2. Canada 4.5.2.1. Canada At-Home Testing Market Size and Forecast, by Product (2023-2030) 4.5.2.1.1. Kits 4.5.2.1.2. Devices 4.5.2.1.3. Strips 4.5.2.2. Canada At-Home Testing Market Size and Forecast, by Sample (2023-2030) 4.5.2.2.1. Blood 4.5.2.2.2. Urine 4.5.2.2.3. Stool 4.5.2.3. Canada At-Home Testing Market Size and Forecast, by Application (2023-2030) 4.5.2.3.1. Blood Pressure Test 4.5.2.3.2. Diabetes and Glucose Tests 4.5.2.3.3. Cholesterol and Triglycerides Tests 4.5.2.3.4. Pregnancy Test 4.5.2.3.5. STD /STI Test 4.5.2.3.6. Urinary Tract Infection Test 4.5.2.3.7. Cancer Test 4.5.2.3.8. Celiac disease Test 4.5.2.3.9. Thyroid Test 4.5.2.3.10. Transaminase Test 4.5.2.3.11. Anemia Test 4.5.2.3.12. Allergy Test 4.5.2.4. Canada At-Home Testing Market Size and Forecast, by End User (2023-2030) 4.5.2.4.1. Retail Pharmacies 4.5.2.4.2. Hospital Pharmacies 4.5.2.4.3. Online Pharmacies 4.5.3. Mexico 4.5.3.1. Mexico At-Home Testing Market Size and Forecast, by Product (2023-2030) 4.5.3.1.1. Kits 4.5.3.1.2. Devices 4.5.3.1.3. Strips 4.5.3.2. Mexico At-Home Testing Market Size and Forecast, by Sample (2023-2030) 4.5.3.2.1. Blood 4.5.3.2.2. Urine 4.5.3.2.3. Stool 4.5.3.3. Mexico At-Home Testing Market Size and Forecast, by Application (2023-2030) 4.5.3.3.1. Blood Pressure Test 4.5.3.3.2. Diabetes and Glucose Tests 4.5.3.3.3. Cholesterol and Triglycerides Tests 4.5.3.3.4. Pregnancy Test 4.5.3.3.5. STD /STI Test 4.5.3.3.6. Urinary Tract Infection Test 4.5.3.3.7. Cancer Test 4.5.3.3.8. Celiac disease Test 4.5.3.3.9. Thyroid Test 4.5.3.3.10. Transaminase Test 4.5.3.3.11. Anemia Test 4.5.3.3.12. Allergy Test 4.5.3.4. Mexico At-Home Testing Market Size and Forecast, by End User (2023-2030) 4.5.3.4.1. Retail Pharmacies 4.5.3.4.2. Hospital Pharmacies 4.5.3.4.3. Online Pharmacies 5. Europe At-Home Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.2. Europe At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.3. Europe At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.4. Europe At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5. Europe At-Home Testing Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.1.2. United Kingdom At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.1.3. United Kingdom At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.1.4. United Kingdom At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.2. France 5.5.2.1. France At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.2.2. France At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.2.3. France At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.2.4. France At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.3. Germany 5.5.3.1. Germany At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.3.2. Germany At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.3.3. Germany At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.3.4. Germany At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.4. Italy 5.5.4.1. Italy At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.4.2. Italy At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.4.3. Italy At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.4.4. Italy At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.5. Spain 5.5.5.1. Spain At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.5.2. Spain At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.5.3. Spain At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.5.4. Spain At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.6.2. Sweden At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.6.3. Sweden At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.6.4. Sweden At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.7. Austria 5.5.7.1. Austria At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.7.2. Austria At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.7.3. Austria At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.7.4. Austria At-Home Testing Market Size and Forecast, by End User (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe At-Home Testing Market Size and Forecast, by Product (2023-2030) 5.5.8.2. Rest of Europe At-Home Testing Market Size and Forecast, by Sample (2023-2030) 5.5.8.3. Rest of Europe At-Home Testing Market Size and Forecast, by Application (2023-2030) 5.5.8.4. Rest of Europe At-Home Testing Market Size and Forecast, by End User (2023-2030) 6. Asia Pacific At-Home Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.2. Asia Pacific At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.3. Asia Pacific At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.4. Asia Pacific At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5. Asia Pacific At-Home Testing Market Size and Forecast, by Country (2023-2030) 6.5.1. China 6.5.1.1. China At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.1.2. China At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.1.3. China At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.1.4. China At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.2.2. S Korea At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.2.3. S Korea At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.2.4. S Korea At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.3. Japan 6.5.3.1. Japan At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.3.2. Japan At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.3.3. Japan At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.3.4. Japan At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.4. India 6.5.4.1. India At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.4.2. India At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.4.3. India At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.4.4. India At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.5. Australia 6.5.5.1. Australia At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.5.2. Australia At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.5.3. Australia At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.5.4. Australia At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.6.2. Indonesia At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.6.3. Indonesia At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.6.4. Indonesia At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.7.2. Malaysia At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.7.3. Malaysia At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.7.4. Malaysia At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.8.2. Vietnam At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.8.3. Vietnam At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.8.4. Vietnam At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.9.2. Taiwan At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.9.3. Taiwan At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.9.4. Taiwan At-Home Testing Market Size and Forecast, by End User (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific At-Home Testing Market Size and Forecast, by Product (2023-2030) 6.5.10.2. Rest of Asia Pacific At-Home Testing Market Size and Forecast, by Sample (2023-2030) 6.5.10.3. Rest of Asia Pacific At-Home Testing Market Size and Forecast, by Application (2023-2030) 6.5.10.4. Rest of Asia Pacific At-Home Testing Market Size and Forecast, by End User (2023-2030) 7. Middle East and Africa At-Home Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa At-Home Testing Market Size and Forecast, by Product (2023-2030) 7.2. Middle East and Africa At-Home Testing Market Size and Forecast, by Sample (2023-2030) 7.3. Middle East and Africa At-Home Testing Market Size and Forecast, by Application (2023-2030) 7.4. Middle East and Africa At-Home Testing Market Size and Forecast, by End User (2023-2030) 7.5. Middle East and Africa At-Home Testing Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa At-Home Testing Market Size and Forecast, by Product (2023-2030) 7.5.1.2. South Africa At-Home Testing Market Size and Forecast, by Sample (2023-2030) 7.5.1.3. South Africa At-Home Testing Market Size and Forecast, by Application (2023-2030) 7.5.1.4. South Africa At-Home Testing Market Size and Forecast, by End User (2023-2030) 7.5.2. GCC 7.5.2.1. GCC At-Home Testing Market Size and Forecast, by Product (2023-2030) 7.5.2.2. GCC At-Home Testing Market Size and Forecast, by Sample (2023-2030) 7.5.2.3. GCC At-Home Testing Market Size and Forecast, by Application (2023-2030) 7.5.2.4. GCC At-Home Testing Market Size and Forecast, by End User (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria At-Home Testing Market Size and Forecast, by Product (2023-2030) 7.5.3.2. Nigeria At-Home Testing Market Size and Forecast, by Sample (2023-2030) 7.5.3.3. Nigeria At-Home Testing Market Size and Forecast, by Application (2023-2030) 7.5.3.4. Nigeria At-Home Testing Market Size and Forecast, by End User (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A At-Home Testing Market Size and Forecast, by Product (2023-2030) 7.5.4.2. Rest of ME&A At-Home Testing Market Size and Forecast, by Sample (2023-2030) 7.5.4.3. Rest of ME&A At-Home Testing Market Size and Forecast, by Application (2023-2030) 7.5.4.4. Rest of ME&A At-Home Testing Market Size and Forecast, by End User (2023-2030) 8. South America At-Home Testing Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America At-Home Testing Market Size and Forecast, by Product (2023-2030) 8.2. South America At-Home Testing Market Size and Forecast, by Sample (2023-2030) 8.3. South America At-Home Testing Market Size and Forecast, by Application(2023-2030) 8.4. South America At-Home Testing Market Size and Forecast, by End User (2023-2030) 8.5. South America At-Home Testing Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil At-Home Testing Market Size and Forecast, by Product (2023-2030) 8.5.1.2. Brazil At-Home Testing Market Size and Forecast, by Sample (2023-2030) 8.5.1.3. Brazil At-Home Testing Market Size and Forecast, by Application (2023-2030) 8.5.1.4. Brazil At-Home Testing Market Size and Forecast, by End User (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina At-Home Testing Market Size and Forecast, by Product (2023-2030) 8.5.2.2. Argentina At-Home Testing Market Size and Forecast, by Sample (2023-2030) 8.5.2.3. Argentina At-Home Testing Market Size and Forecast, by Application (2023-2030) 8.5.2.4. Argentina At-Home Testing Market Size and Forecast, by End User (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America At-Home Testing Market Size and Forecast, by Product (2023-2030) 8.5.3.2. Rest Of South America At-Home Testing Market Size and Forecast, by Sample (2023-2030) 8.5.3.3. Rest Of South America At-Home Testing Market Size and Forecast, by Application (2023-2030) 8.5.3.4. Rest Of South America At-Home Testing Market Size and Forecast, by End User (2023-2030) 9. Global At-Home Testing Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading At-Home Testing Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. BD (Becton, Dickinson and Company) (U.S.) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. LifeScan IP Holdings, LLC (U.S.) 10.3. Abbott (U.S.) 10.4. ACON Laboratories, Inc. (U.S.) 10.5. Quidel Corporation (U.S.) 10.6. ARKRAY USA, Inc. (U.S.) 10.7. Nova Biomedical (U.S.) 10.8. Cardinal Health (U.S.) 10.9. OraSure Technologies (U.S.) 10.10. Everlywell, Inc. (U.S.) 10.11. SA Scientific Ltd. (U.S.) 10.12. MP BIOMEDICALS (U.S.) 10.13. Chembio Diagnostics, Inc. (U.S.) 10.14. BTNX INC. (Canada) 10.15. Biolytical Laboratories Inc. (Canada) 10.16. Siemens Healthcare GmbH (Germany) 10.17. Drägerwerk AG & Co. KGaA (Germany) 10.18. F. Hoffmann-La Roche Ltd (Switzerland) 10.19. Ascensia Diabetes Care Holdings AG (Switzerland) 10.20. PRIMA Lab SA (Switzerland) 10.21. BioSure (U.K.) 10.22. Sterilab Services (France) 10.23. Biosynex (France) 11. Key Findings 12. Industry Recommendations 13. At-Home Testing Market: Research Methodology 14. Terms and Glossary